Smooth muscle cell-specific deletion of gasdermin D also attenuated aneurysm diameter expansion and reduced AAA incidence in experimental AAAs created by subcutaneous Ang II infusion or topical application of elastase to aortic adventitia [51]. This evidence concerns the gene GSDMD and achalasia-alacrima syndrome.